DKSH and Osteopore Partner to Strengthen Distribution of Regenerative Dental Solutions in Malaysia

DKSH has entered into a strategic partnership with Osteopore to provide comprehensive commercial and logistics services for its advanced regenerative dental product portfolio in Malaysia. This collaboration reinforces DKSH’s commitment to expanding access to innovative medical technologies while strengthening Osteopore’s presence in the Malaysian dental market.

Petaling Jaya, Malaysia, February 19, 2026 – DKSH Business Unit Healthcare, a leading partner for companies seeking to grow their healthcare business in Asia and beyond, has entered into a strategic partnership with Osteopore Limited, a global leader in 3D-printed biomimetic and bioresorbable implants, to enhance the distribution, commercial coverage, and operational excellence of its dental solutions in Malaysia.

Through this collaboration, DKSH will support the nationwide distribution of Osteopore’s advanced dental products, expanding access to innovative regenerative technologies for dental professionals across the country. Under the agreement, DKSH will provide full market expansion services, including sales, marketing, distribution and logistics, as well as customer engagement and channel management, to drive Osteopore’s growth across key healthcare and dental channels.

This partnership builds on DKSH’s strong track record in healthcare distribution and its role as a trusted partner to leading medical technology and life sciences companies. By combining Osteopore’s product innovation with DKSH’s extensive commercial capabilities, both organizations aim to accelerate market adoption and further enhance standards of care in dental and regenerative medicine.

Dr Yujing Lim, Chief Executive Officer at Osteopore Limited commented: “We are glad to have secured a partnership with DKSH Malaysia shortly after the clinical study about comparing Osteopore’s polycaprolactone membrane with a collagen membrane. With local clinical data being generated by the leading research university hospital, University Malaysia (UM) in Malaysia, we can expect to leverage the clinical outcomes to support in-market adoption. As we continue to realign and strengthen our sales and distribution channels in a progressive and organized manner, we look forward to a strong partnership with DKSH Malaysia to introduce a technology that is experiencing growing traction in the market.”

Sandeep Tewari, Vice President, Healthcare and Head, Country Leadership, Malaysia, DKSH added: “Osteopore’s technology has the potential to be first-in-class in Malaysia, and we are excited to support the launch of this innovative solution and to make it accessible to healthcare professionals and patients across the market. Clinicians within our network have expressed strong interest in Osteopore’s products, especially when bone regrowth and augmentation are required. This partnership reinforces DKSH’s commitment to providing healthcare for all by delivering advanced medical innovations that elevate the standard of care across Malaysia.”

Together, DKSH and Osteopore and DKSH Malaysia are committed to driving strong and sustainable growth for the brand, supported by increasing clinical adoption and expanding market reach nationwide, providing healthcare for all.